SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ZIM Laboratories gets Marketing Authorization for Tamsulosin Hydrochloride and Dutasteride Capsules in Australia

04 Aug 2025 Evaluate

Zim Laboratories has received Marketing Authorization from Therapeutic Goods Administration (TGA) for its Urology product ‘Tamsulosin Hydrochloride and Dutasteride Capsules’ through its Australian subsidiary, ZIMTAS. This approval marks ZIM’s second Marketing Authorization in Australia and is an important milestone in the company’s strategy to expand its presence in regulated markets through innovative drug delivery technologies.

Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men. The fixed-dose combination (FDC) formulation improves patient compliance by combining two essential medications into a single daily dose, offering both rapid symptom relief and long-term disease modification. This achievement aligns with ZIM’s strategy to leverage its development and manufacturing expertise to build a robust pipeline of differentiated generics for global markets. 

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.


Zim Laboratories Share Price

72.69 -0.38 (-0.52%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×